The markets consolidated throughout the past week; the week was a shortened one with Monday, June 17th being a…
Last week, the broader market Indices hit another new high on Thursday before pulling back into Friday’s close. Not…
In this StockCharts TV video, Mary Ellen reviews the broader markets, takes a close look at NVDA and other year-to-date…
Moving averages are a crucial charting tool, but many of us aren’t getting the most out of them. In…
Who would have thought a mid-week break would halt the stock market’s winning streak? Maybe the hot PMI reading…
In this edition of StockCharts TV’s The Final Bar, Dave answers viewer questions on using technical indicators on leveraged and inverse…
In this edition of StockCharts TV’s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like…
Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing to do with…
Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing…